The mechanism of insertional Achilles tendinopathy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100054633

Enrollment

Unknown

Registered

2021-12-22

Start date

2021-05-06

Completion date

Unknown

Last updated

2022-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insertional Achilles tendinopathy

Interventions

Achilles tendinopathy Group:No Intervention

Non-Achilles tendinopathy Group:No Intervention

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. Patients clinically diagnosed with Achilles insertion tendinopathy (including ectopic ossification of Achilles insertion, calcification of Achilles insertion, Achilles insertion inflammation, Haglund syndrome, etc.) who need to be hospitalized for removal of Achilles insertion; 2. Patients with Achilles tendon insertion tendinopathy complicated with Achilles tendon rupture requiring surgical treatment; 3. Voluntarily participate in the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with gout, rheumatoid arthritis and other diseases; 2. Patients with peripheral Achilles tendon infection; 3. Any more complex medical problems that may interfere with the conduct of the study or lead to increased risk, such as malignant tumors, blood diseases, AIDS, viral hepatitis, etc.

Design outcomes

Primary

Measure	Time frame
AOFAS Score;Single cell sequencing;	—

Countries

China

Contacts

Public ContactKanglai Tang

The First Affiliated Hospital of Army Medical University

tangkanglai@hotmail.com+86 13983681188

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026